Skip to main content

Poolbeg Pharma announces expansion of POLB 001 into oncology

--News Direct--

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a new oncological indication. Skillington explains the reasons for the strategic expansion and reveals more about his vision for the molecule in the long term.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-announces-expansion-of-polb-001-into-oncology-711615119

Recent Quotes

View More
Symbol Price Change (%)
AMZN  214.45
+1.41 (0.66%)
AAPL  258.45
+6.16 (2.44%)
AMD  236.31
+3.22 (1.38%)
BAC  51.62
+0.34 (0.67%)
GOOG  256.32
+2.53 (1.00%)
META  722.78
+5.87 (0.82%)
MSFT  515.05
+1.47 (0.29%)
NVDA  182.54
-0.68 (-0.37%)
ORCL  283.30
-8.01 (-2.75%)
TSLA  444.94
+5.62 (1.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.